The world market in 2005 for In Vitro Diagnostics will be in excess of $20bn - can you afford to ignore this market?

The largest market is for Molecular Diagnostics, taking a 42% market share, and growing. Visiongain's new report on In Vitro Diagnostics gives you an in-depth examination of how you and your company can secure or increase your market share today. As to be expected the US dominates this market, whilst Germany has the largest market in Europe and surprisingly is the third in the world.

Nucleic Acid testing is the fastest growing market and is a key growth area. Growth in the total world market is estimated to be in the region of 7%.

Visiongain's
World Market for In Vitro Diagnostics Report
2005 covers the following topics with revenues and market share by country for most applications:

• Regulation
• Molecular Technologies
• Nucleic Acid Testing
• Protein Chip Technologies
• In Vitro Diagnostics at Point of Care Use
• Personal use of In Vitro Diagnostics
• Future Use of In Vitro Diagnostics in Diabetes
• Future Use of In Vitro Diagnostics in Cancer
• In Vitro Diagnostics in Cardiac Monitoring
• Genetic Testing
• Future Markets
• Future Growth Areas

Why You Must Buy this Report?

With over 30 tables, news, insights, the latest developments, and a complete survey of the World Market for In Vitro Diagnostics. This report is a vital addition in the understanding of this lucrative and fast growing market arena. You can not afford to do without this latest report from visiongain. We look forward to receiving your order.